UK Rare Disease Genetic Testing Market Size & Outlook
UK rare disease genetic testing market, 2016-2028 (US$M)
Related Markets
UK rare disease genetic testing market highlights
- The UK rare disease genetic testing market generated a revenue of USD 18.8 million in 2020 and is expected to reach USD 49.6 million by 2028.
- The UK market is expected to grow at a CAGR of 12.9% from 2021 to 2028.
- In terms of segment, immunological disorders was the largest revenue generating disease type in 2020.
- Cardiovascular Disorders is the most lucrative disease type segment registering the fastest growth during the forecast period.
Rare disease genetic testing market data book summary
| Market revenue in 2020 | USD 18.8 million |
| Market revenue in 2028 | USD 49.6 million |
| Growth rate | 12.9% (CAGR from 2020 to 2028) |
| Largest segment | Immunological disorders |
| Fastest growing segment | Cardiovascular Disorders |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disease |
| Key market players worldwide | Quest Diagnostics Inc, Centogene NV Ordinary Shares, Invitae Corp, Eurofins Scientific SE, PerkinElmer, Macrogenics Inc, Fulgent Genetics Inc, Myriad Genetics Inc, Labcorp Holdings Inc, OPKO Health Inc, 3billion, ARUP Laboratories, Strand Life Sciences, Ambry Genetics, REALM IDx, Inc., Baylor Genetics, Health Network Laboratories, PreventionGenetics, Biora Therapeutics, CooperSurgical, Artemis DNA |
Other key industry trends
- In terms of revenue, UK accounted for 2.4% of the global rare disease genetic testing market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany rare disease genetic testing market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 49.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Disease Genetic Testing Market Scope
Rare Disease Genetic Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK rare disease genetic testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare disease genetic testing market will help companies and investors design strategic landscapes.
Immunological disorders was the largest segment with a revenue share of 13.3% in 2020. Horizon Databook has segmented the UK rare disease genetic testing market based on neurological disorders, immunological disorders, hematology diseases, endocrine & metabolism diseases, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology disease covering the revenue growth of each sub-segment from 2016 to 2028.
The UK government has published the UK Strategy for Rare Diseases in 2013, a high-level framework, as a strategic vision for 2013-2020 that covers various key areas including diagnosis & early intervention; empowering patient with rare diseases; identification and prevention of rare diseases; and others.
In February 2019, an update to the implementation plan of this strategy for England was published. Such initiatives by government bodies in the country is one of the key driving forces of this market. In April 2019, Clinithink announced its partnership with Rady Children’s Institute.
For Genomic Medicine (RGIGM) for diagnosis of rare genetic diseases in record time using machine learning process and clinical natural language processing. Such collaborations are expected to expand the use of genome sequencing as a first-line diagnostic test for children with rare genetic disorders.
Reasons to subscribe to UK rare disease genetic testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK rare disease genetic testing market databook
-
Our clientele includes a mix of rare disease genetic testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK rare disease genetic testing market , including forecasts for subscribers. This country databook contains high-level insights into UK rare disease genetic testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
UK Rare Disease Genetic Testing Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
